| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/30/2007 | US7169776 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 01/30/2007 | US7169767 Ophthalmic compositions containing galactomannan polymers and borate |
| 01/30/2007 | US7169763 Cytochrome P450 3A inhibitors and enhancers |
| 01/30/2007 | US7169760 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 01/30/2007 | US7169758 Use of hepcidin as a regulator of iron homeostasis |
| 01/30/2007 | US7169746 For effecting mental control through psycho-sedation or psycho-stimulation |
| 01/30/2007 | US7169607 In vivo induction for enhanced function of isolated hepatocytes |
| 01/30/2007 | US7169605 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 01/30/2007 | US7169603 Nucleic acid; a nucleotide sequence encoding a fusion polypeptide; fusion polypeptides containing alpha -MSH can be used to elicit a variety of biological responses, in vitro and in vivo |
| 01/30/2007 | US7169594 detecting the presence or absence of increased S6 kinase activity in said biological sample. |
| 01/30/2007 | US7169559 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets |
| 01/30/2007 | US7169399 Administering intranasally an antigen which is a non-toxic double mutant form of pertussis toxin inducing an immune response |
| 01/30/2007 | US7169395 combining a mixture of RSV proteins with non-virulent influenza virus in a vaccine formulation provides an immune response which is substantially the same as the response obtained by administration of the components individually |
| 01/30/2007 | US7169387 Monoclonal antibodies orsoluble immunoglobulin fusion protein; block multiple sclerosis |
| 01/30/2007 | US7169385 Solubilized CoQ-10 and carnitine |
| 01/30/2007 | US7169382 Reconstructed epidermis/skin equivalent comprising a ceramide 7 and /or 5.5 and lipid lamellar vesicular compositions comprising ceramide 7 and/or 5.5 compounds |
| 01/30/2007 | US7169378 Delivery of opioids through an inhalation route |
| 01/30/2007 | CA2484115C Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases |
| 01/30/2007 | CA2411153C Method for preparing a composition |
| 01/30/2007 | CA2350573C Piperidines as ccr5 modulators |
| 01/30/2007 | CA2302017C Prevention of adhesions and excessive scar formation using angiogenesis inhibitors |
| 01/30/2007 | CA2185794C Agent for relieving side effects caused by immunosuppressants |
| 01/30/2007 | CA2107537C Inhibition of tumor cell growth by administration of b7-transfected cells |
| 01/25/2007 | WO2007011072A1 Premature ovulation preventive agent |
| 01/25/2007 | WO2007010692A1 Pharmaceutical composition for treatment of inflammatory bowel disease which targets at hvem and btla, and therapeutic method |
| 01/25/2007 | WO2007010628A1 Prophylactic/therapeutic agent for cancer |
| 01/25/2007 | WO2007010312A2 Use of mmp inhibitors for the preparation of pharmaceutical compositions of cardioprotective effect |
| 01/25/2007 | WO2007010216A1 Lycopene formulations for the treatment of atherosclerotic conditions |
| 01/25/2007 | WO2007009539A2 Use of inhibitors of histone deacetylases in combination with nsaid for the therapy of cancer and/or inflammatory diseases |
| 01/25/2007 | WO2007009462A2 Treatment of migraine and headaches |
| 01/25/2007 | WO2007009264A1 Chemotherapeutic agents for inhibition of protein translation |
| 01/25/2007 | WO2006119168A3 Use of carotenoids and/or carotenoid derivatives/analogs for reduction/inhibition of certain negative effects of cox inhibitors |
| 01/25/2007 | WO2006110176A3 Combined treatment with radiation and an epidermal growth factor receptor kinase inhibitor |
| 01/25/2007 | WO2006108430A8 Nutrient composition comprising green tea polyphenols for treating osteosarcoma |
| 01/25/2007 | WO2006096285A3 Compositions and methods for treating or preventing flaviviridae infections |
| 01/25/2007 | US20070021509 Phosphate transport inhibitors |
| 01/25/2007 | US20070021496 Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass |
| 01/25/2007 | US20070021491 Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
| 01/25/2007 | US20070021440 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 01/25/2007 | US20070021391 Preventive/remedy for urinary disturbance |
| 01/25/2007 | US20070021386 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 01/25/2007 | US20070021360 Compositions, formulations and kit with anti-sense oligonucleotide and anti-inflammatory steroid and/or obiquinone for treatment of respiratory and lung disesase |
| 01/25/2007 | US20070021354 Viricides; immunomoderator; mixture with other Aids drugs |
| 01/25/2007 | US20070021348 Novel treatment |
| 01/25/2007 | US20070021333 Pharmaceutical compositions based on anticholinergics and soluble tnf receptor fusion proteins |
| 01/25/2007 | US20070021326 Composition and its Therapeutic Use |
| 01/25/2007 | US20070020704 Diaryl ureas with kinase inhibiting activity |
| 01/25/2007 | US20070020343 Nutrient supplements and methods for treating autism and for preventing the onset of autism |
| 01/25/2007 | US20070020297 System and method for the treatment of cancer, including cancers of the central nervous system |
| 01/25/2007 | US20070020280 Compositions and methods for inhibition of HIV-1 infection |
| 01/25/2007 | US20070020275 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 01/25/2007 | US20070020268 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 01/25/2007 | US20070020265 administering non-blocking anti-CD20 antibody and carrier; fusion proteins; rheumatoid arthritis |
| 01/25/2007 | US20070020263 Medicine containing genetically modified antibody against chemokine receptor ccr4 |
| 01/25/2007 | US20070020262 Uses of mammalian cytokine: related reagents |
| 01/25/2007 | US20070020254 Methods and compositions for treatment of inflammatory disease |
| 01/25/2007 | US20070020245 Composition for the treatment of arthrosis/arthritis, especially for treating joints |
| 01/25/2007 | US20070020234 Inhibition of tumor angiogenesis by combination of thrombospondin-1 and inhibitors of vascular endothelial growth factor |
| 01/25/2007 | US20070017508 Methods for treating jaw pain |
| 01/25/2007 | CA2615990A1 Enhanced ocular neuroprotection/neurostimulation |
| 01/25/2007 | CA2615795A1 Premature ovulation preventive agent |
| 01/25/2007 | CA2615598A1 Compositions for treatment of systemic mastocytosis |
| 01/25/2007 | CA2615360A1 Formulation and method for administration of ophthalmologically active agents |
| 01/25/2007 | CA2615231A1 Prevention and treatment of ophthalmic complications of diabetes |
| 01/25/2007 | CA2614770A1 The use of inhibitors of histone deacetylases in combination with compounds acting as nsaid for the therapy of human diseases |
| 01/24/2007 | EP1746160A2 Hepatocyte growth factor receptor antagonists and uses thereof |
| 01/24/2007 | EP1746159A2 Immunostimulatory nucleic acid molecules |
| 01/24/2007 | EP1745801A1 Method of inhibiting telomerase activity and inhibitor |
| 01/24/2007 | EP1745800A1 Novel blt2-mediated disease, and blt2 binding agent and compound |
| 01/24/2007 | EP1745799A2 Compositions and methods of treating tumors |
| 01/24/2007 | EP1745797A2 Vascularization inhibitors |
| 01/24/2007 | EP1745790A2 Treatment of rumen acidosis with alpha-amylase inhibitors |
| 01/24/2007 | EP1745779A2 Uses of perfluorinated carboylic acid derivatives for the manufacture of a medicament for the modulation of body mass |
| 01/24/2007 | EP1745125A1 Cell culture environments for the serum-free expansion of mesenchymal stem cells |
| 01/24/2007 | EP1745004A2 Aryl ketone compounds and compositions for delivering active agents |
| 01/24/2007 | EP1744783A1 Compositions comprising cells and magnetic materials for targeted delivery |
| 01/24/2007 | EP1744781A1 Treatment of infectious diseases |
| 01/24/2007 | EP1744768A2 Peritoneal dialysis solution |
| 01/24/2007 | EP1744767A2 Therapeutic delivery system comprising a high molecular weight peg-like compound |
| 01/24/2007 | EP1744749A1 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes |
| 01/24/2007 | EP1744748A2 Method of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myelodysplastic syndromes |
| 01/24/2007 | EP1744734A2 Therapeutic combination comprising a tissue factor antagonist and anti-cancer compounds |
| 01/24/2007 | EP1638547B1 Composition for preventing urinary system infections |
| 01/24/2007 | EP1545495A4 P-glycoprotein inhibitor comprising octilonium bromide as an effective ingredient |
| 01/24/2007 | EP1503714A4 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics |
| 01/24/2007 | EP1481007B1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, treatments and animal models produced therefrom |
| 01/24/2007 | EP1461070B1 Combined use of a glp-1 compound and an aldose reductase inhibitor |
| 01/24/2007 | EP1443967B1 Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination |
| 01/24/2007 | EP1423100B1 Plaster comprising sertaconazole for the treatment of dysfunctions and disorders of nails |
| 01/24/2007 | EP1408939A4 Methods for preparation and use of 1 alpha,24(s)-dihydroxyvitamin d2 |
| 01/24/2007 | EP1374901B1 Graft rejection suppressors |
| 01/24/2007 | EP1341537B1 Pharmaceutically active isoindoline derivatives |
| 01/24/2007 | EP1284750B1 Pharmaceutical composition |
| 01/24/2007 | EP1280531B1 Formulation consisting of phentolamine mesylate and the use thereof |
| 01/24/2007 | EP1265920B9 Angiogenesis-associated proteins, and nucleic acids encoding the same |
| 01/24/2007 | EP1174151B1 Therapeutic treatment of eosinophilia using chymase inhibitors as the active ingredient |
| 01/24/2007 | EP1100507B1 Use of a combination comprising a precursor of uric acid and antioxidant for the treatment of neurodegenerative deseases |
| 01/24/2007 | EP1024812B1 Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof |
| 01/24/2007 | EP0941341B1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
| 01/24/2007 | EP0811073B1 Use of immune modulators for making medicaments ot inhibit immune responses against co-administered recombinant viruses |